All Stories

  1. Deep Brain Stimulation for Stroke: Continuous Stimulation of the Pedunculopontine Tegmental Nucleus has no Impact on Skilled Walking in Rats After Photothrombotic Stroke
  2. Directional deep brain stimulation of the subthalamic nucleus: A pilot study using a novel neurostimulation device
  3. Cognitive outcome of pallidal deep brain stimulation for primary cervical dystonia: One year follow up results of a prospective multicenter trial
  4. The medical treatment of patients with Parkinson's disease receiving subthalamic neurostimulation
  5. Subthalamic nucleus stimulation improves Parkinsonian gait via brainstem locomotor centers
  6. Short pulse width widens the therapeutic window of subthalamic neurostimulation
  7. Selective changes of ocular vestibular myogenic potentials in Parkinson's disease
  8. Full Parkinsonian Triad Induced by Pallidal High-Frequency Stimulation in Cervical Dystonia
  9. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial
  10. Nicotinic Acetylcholine Receptor Density in Cognitively Intact Subjects at an Early Stage of Parkinson’s Disease
  11. Deep brain stimulation for dystonia
  12. Coordinated reset neuromodulation for Parkinson's disease: Proof‐of‐concept study
  13. Subthalamic deep brain stimulation restores automatic response activation and increases susceptibility to impulsive behavior in patients with Parkinson’s disease
  14. The Pirouette Test to Evaluate Asymmetry in Parkinsonian Gait Freezing
  15. Pallidal Deep Brain Stimulation in DYT6: Significant Long-Term Improvement of Dystonia and Disability
  16. Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology
  17. Gait Initiation in Children with Rett Syndrome
  18. Motor outcome of dystonic camptocormia treated with pallidal neurostimulation
  19. Parkinson: Ergebnisse aus der EARLYSTIM-Studie
  20. Neue Studien zur THS in der Neurologie
  21. Primäre Dystonie: Langzeiteffekte der GPi-THS
  22. The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus
  23. Commentary
  24. Deep brain stimulation for gait and postural symptoms in Parkinson's disease
  25. The central oscillatory network of orthostatic tremor
  26. Dystonia rating scales: Critique and recommendations
  27. Botulinum neurotoxin treatment improves force regulation in writer's cramp
  28. Indikation zur THS schon bei ersten Wirkfluktuationen prüfen
  29. Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease
  30. Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review
  31. Postoperative management of deep brain stimulation in Parkinson’s disease
  32. The Influence of Dopaminergic Striatal Innervation on Upper Limb Locomotor Synergies
  33. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial
  34. Deep Brain Stimulation
  35. Differential effect of dopa and subthalamic stimulation on vestibular activity in Parkinson's disease
  36. Lower limb joints kinematics in essential tremor and the effect of thalamic stimulation
  37. Stimulation site within the MRI-defined STN predicts postoperative motor outcome
  38. Deep brain stimulation in Parkinson's disease: opening up the race towards better technology
  39. The atypical subthalamic nucleus-An anatomical variant relevant for stereotactic targeting
  40. Neuropsychiatric Side Effects of Deep Brain Stimulation in Parkinson’s Disease
  41. Factors associated with neuropsychiatric side effects after STN-DBS in Parkinson's disease
  42. A role for locus coeruleus in Parkinson tremor
  43. The Wilson films - Parkinson's disease
  44. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease
  45. Levetiracetam in primary orthostatic tremor: A double-blind placebo-controlled crossover study
  46. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
  47. Identification and functional analysis of novel THAP1 mutations
  48. No evidence for THAP1 /DYT6 variants as disease modifiers in DYT1 dystonia
  49. Axonal failure during high frequency stimulation of rat subthalamic nucleus
  50. Subthalamic deep brain stimulation increases pallidal firing rate and regularity
  51. Long-Term management of DBS in dystonia: Response to stimulation, adverse events, battery changes, and special considerations
  52. Deep brain stimulation: management of patients after surgery
  53. Successful deep brain stimulation in a case of posttraumatic tremor and hemiparkinsonism
  54. Modulation of gait coordination by subthalamic stimulation improves freezing of gait
  55. Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease duration
  56. Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation
  57. Deep Brain Stimulation for Parkinson Disease
  58. Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease
  59. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease
  60. Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease
  61. Camptocormia in idiopathic Parkinson's disease: A focal myopathy of the paravertebral muscles
  62. Secondary failure after ten years of pallidal neurostimulation in a patient with advanced Parkinson’s disease
  63. Proprioception and Motor Control in Parkinson's Disease
  64. Cortical correlates of the basic and first harmonic frequency of Parkinsonian tremor
  65. ATP13A2 variants in early-onset Parkinson's disease patients and controls
  66. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease
  67. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease
  68. Selecting appropriate Parkinson's patients for Deep Brain Stimulation (DBS)
  69. Acquired stuttering after pallidal deep brain stimulation for dystonia
  70. Effect of Cabergoline on Parkinsonian Tremor Assessed by Long-Term Actigraphy
  71. Subthalamic nucleus stimulation restores corticospinal facilitation in Parkinson's disease
  72. Surgery for Parkinson's Disease
  73. Oscillations of the Human Sensorimotor System as Revealed by Magnetoencephalography
  74. High-frequency stimulation of the subthalamic nucleus increases pallidal neuronal firing rate in a patient with Parkinson's disease
  75. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study
  76. Deep brain stimulation in Parkinson's disease following fetal nigral transplantation
  77. Intra-operative Microrecording and Stimulation
  78. Novel Treatment Options for Advanced Parkinson’s Disease
  79. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: Results from a prospective, randomized sham-controlled trial
  80. 1.IS.1. New paradigm shifts in deep brain stimulation (Medtronic)
  81. Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration
  82. Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia
  83. The impact of normal aging and Parkinson's disease on response preparation in task-switching behavior
  84. A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
  85. Differential Effects of L-Dopa and Subthalamic Stimulation on Depressive Symptoms and Hedonic Tone in Parkinson's Disease
  86. Nicht-medikamentöse neurochirurgische Parkinson-Therapie: Zunehmend wichtige Rolle in der Therapie
  87. Basic algorithms for the programming of deep brain stimulation in Parkinson's disease
  88. Patients with Parkinson's disease learn to control complex systems—an indication for intact implicit cognitive skill learning
  89. RecurrentLRRK2 (Park8) mutations in early-onset Parkinson's disease
  90. Deep brain stimulation: Postoperative issues
  91. Praying-induced oromandibular dystonia
  92. Deep brain stimulation in late stage Parkinson?s disease: a retrospective cost analysis in Germany
  93. Premutations in theFMR1 gene as a modifying factor inParkin-associated Parkinson's disease?
  94. Pallidal Stimulation for Dystonia
  95. Depression and Parkinson?s disease
  96. Dementia in idiopathic Parkinson?s syndrome
  97. Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease
  98. 786 Targeting of the Subthalamic Area Is Superior to the Ventrolateral Thalamus for Severe Intention Tremor, and Asymmetric Stimulation Can Prevent Side Effects
  99. 786 Targeting of the Subthalamic Area Is Superior to the Ventrolateral Thalamus for Severe Intention Tremor, and Asymmetric Stimulation Can Prevent Side Effects
  100. Tiefe Hirnstimulation
  101. Deep Brain Stimulation for the Treatment of Parkinson’s Disease
  102. Long-term results of bilateral pallidal stimulation in Parkinson's disease
  103. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease
  104. Deep Brain Stimulation of the Subthalamic Nucleus Enhances Emotional Processing in Parkinson Disease
  105. Chapter 24 Clinical neurophysiology and pathophysiology of Parkinsonian tremor
  106. Effect of subthalamic deep brain stimulation on the function of the urinary bladder
  107. Deep brain stimulation for movement disorders
  108. Deep brain stimulation for dystonia: Patient selection and evaluation
  109. Introduction to the programming of deep brain stimulators
  110. Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position
  111. Synchronization tomography: Synchronization analysis of MEG current density solutions in patients with Parkinson's disease
  112. Visual Hallucinations in Recovery From Cortical Blindness
  113. Different cortical organization of visceral and somatic sensation in humans
  114. Complex Phase Synchronization in Neurophysiological Data
  115. Dichotic listening: What does it measure?
  116. Anatomical left-right asymmetry of language-related temporal cortex is different in left- and right-handers
  117. Is Surgical Treatment an Option for Chorea-Acanthocytosis?
  118. Pallidal Deep Brain Stimulation for Parkinson's Disease
  119. Surgical treatment and behavior